Jeffrey A. Singer In March 2020, as the COVID-19 pandemic made it more difficult for people with opioid use disorder (OUD) to access daily methadone treatment at federally‐approved opioid treatment programs (OTPs), the Substance Abuse and Mental Health Services Administration (SAMHSA) temporarily liberalized methadone take‐home rules